FR2215942A1 - - Google Patents

Info

Publication number
FR2215942A1
FR2215942A1 FR7403339A FR7403339A FR2215942A1 FR 2215942 A1 FR2215942 A1 FR 2215942A1 FR 7403339 A FR7403339 A FR 7403339A FR 7403339 A FR7403339 A FR 7403339A FR 2215942 A1 FR2215942 A1 FR 2215942A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7403339A
Other versions
FR2215942B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FR2215942A1 publication Critical patent/FR2215942A1/fr
Application granted granted Critical
Publication of FR2215942B1 publication Critical patent/FR2215942B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1896—Compounds having one or more Si-O-acyl linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7403339A 1973-01-31 1974-01-31 Expired FR2215942B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32823473A 1973-01-31 1973-01-31
US36169673A 1973-05-18 1973-05-18

Publications (2)

Publication Number Publication Date
FR2215942A1 true FR2215942A1 (fr) 1974-08-30
FR2215942B1 FR2215942B1 (fr) 1978-12-22

Family

ID=26986279

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7403339A Expired FR2215942B1 (fr) 1973-01-31 1974-01-31
FR7825299A Granted FR2391728A1 (fr) 1973-01-31 1978-09-01 Application pharmacologique de cephalosporines

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR7825299A Granted FR2391728A1 (fr) 1973-01-31 1978-09-01 Application pharmacologique de cephalosporines

Country Status (7)

Country Link
JP (1) JPS5953275B2 (fr)
CA (1) CA1035353A (fr)
DE (1) DE2404592C2 (fr)
FR (2) FR2215942B1 (fr)
GB (1) GB1439419A (fr)
NL (1) NL7401361A (fr)
PH (2) PH16419A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL49183A0 (en) * 1975-03-27 1976-05-31 Pfizer Novel cephalosporin derivatives,their preparation and pharmaceutical compositions containing them

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1297069A (fr) * 1969-04-21 1972-11-22
FR2187299A1 (fr) * 1972-06-14 1974-01-18 Smith Kline French Lab
FR2187305A1 (fr) * 1972-06-14 1974-01-18 Smith Kline French Lab

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7112483A (fr) * 1970-09-14 1972-03-16
IL38099A (en) * 1970-12-17 1976-01-30 Smith Kline French Lab 3-heterocyclyl thiomethylcephalosporins
YU36967B (en) * 1971-01-18 1984-08-31 Bristol Myers Co Process for the production of antibacterial agents
US3757014A (en) * 1971-05-07 1973-09-04 Bristol Myers Co Ts 1,3,4 - oxadiazol-2-yl)thiomethyl)-3-cephem-4-carboxylic acid and sal7-(d-(alpha-amino-alpha-pheyle-acetamido)) - 3-(s-(5-hydroxymethyl -

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1297069A (fr) * 1969-04-21 1972-11-22
FR2187299A1 (fr) * 1972-06-14 1974-01-18 Smith Kline French Lab
FR2187298A1 (fr) * 1972-06-14 1974-01-18 Smith Kline French Lab
FR2187305A1 (fr) * 1972-06-14 1974-01-18 Smith Kline French Lab

Also Published As

Publication number Publication date
FR2391728A1 (fr) 1978-12-22
DE2404592A1 (de) 1974-08-01
FR2215942B1 (fr) 1978-12-22
CA1035353A (fr) 1978-07-25
JPS49101395A (fr) 1974-09-25
FR2391728B1 (fr) 1982-08-20
PH14842A (en) 1981-12-16
GB1439419A (en) 1976-06-16
NL7401361A (fr) 1974-08-02
JPS5953275B2 (ja) 1984-12-24
PH16419A (en) 1983-09-29
DE2404592C2 (de) 1984-01-19

Similar Documents

Publication Publication Date Title
AU476761B2 (fr)
AU474593B2 (fr)
AU474511B2 (fr)
AU474838B2 (fr)
AU471343B2 (fr)
AU476714B2 (fr)
AU476696B2 (fr)
AU472848B2 (fr)
FR2215942B1 (fr)
AU477823B2 (fr)
AU471461B2 (fr)
AU477824B2 (fr)
AR193950A1 (fr)
AU476873B1 (fr)
BG18644A1 (fr)
AU479422A (fr)
CH1501974A4 (fr)
BG22055A3 (fr)
BG20014A1 (fr)
BG19229A1 (fr)
BG18963A1 (fr)
CH563156A5 (fr)
AU482283A (fr)
AU479562A (fr)
AU479539A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse